Basit öğe kaydını göster

Neadjuvant Chemotherapy (NACT) with Epirubicin (EPI) Cisplatin (CDDP), Bleomycin (BLEO) (BEC) in Undifferentiated nasopharyngeal cancer (UCNT): Preliminary results an international (Int.) phase (PH) III trial

dc.contributor.authorCvitkovic, E
dc.contributor.authorAltun, Musa
dc.date.accessioned2021-03-03T11:09:07Z
dc.date.available2021-03-03T11:09:07Z
dc.identifier.citationCvitkovic E., Altun M., "Neadjuvant Chemotherapy (NACT) with Epirubicin (EPI) Cisplatin (CDDP), Bleomycin (BLEO) (BEC) in Undifferentiated nasopharyngeal cancer (UCNT): Preliminary results an international (Int.) phase (PH) III trial", American Society of Clinical Oncology : thirtieth annual meeting, May 14-17, 1994, Texas, Amerika Birleşik Devletleri, 14 - 17 Mayıs 1994, ss.283
dc.identifier.otherav_263aa632-a7bd-4f42-ba1d-90b72a8b305b
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/30597
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectTIP, GENEL & İÇECEK
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.subjectMedicine (miscellaneous)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleNeadjuvant Chemotherapy (NACT) with Epirubicin (EPI) Cisplatin (CDDP), Bleomycin (BLEO) (BEC) in Undifferentiated nasopharyngeal cancer (UCNT): Preliminary results an international (Int.) phase (PH) III trial
dc.typeBildiri
dc.contributor.department, ,
dc.contributor.firstauthorID2504524


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster